SUMMARY: FDA In Brief: FDA takes new steps to help mitigate overprescribing of opioid medications as effort to reduce rates of new addiction
-
Revised Prescriber Education Blueprint- Expanding the required training for opioid prescribers to include information on acute and chronic pain management, addiction medicine, opioid use disorders, and non-opioid treatment options. This training will now be available to a broader group of healthcare providers, including nurses and pharmacists.
-
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)- Ensuring that drug manufacturers provide comprehensive educational resources to prescribers about safe opioid prescribing and pain management
-
Public Hearings and Stakeholders Input- Engaging with healthcare professionals, policymakers, and experts to explore strategies for improving opioid prescribing practices and reducing addiction risks.
-
Utilization of Electronic Prescribing Systems and Drug monitoring Programs- Encouraging the integration of electronic prescribing and state prescription drug monitoring programs to track and regulate opioid prescriptions more effectively.
-
Exploring Packaging, Storage, and Disposal Solutions- Investing ways to improve opioid packaging and disposal to prevent misuse and overuse.
on the uploaded document.
0 General Document comments
0 Sentence and Paragraph comments
0 Image and Video comments
General Document Comments 0
